It is noted that its shares currently lie at $1.64. Don't be alittle stun now, after all, it came to cost only $1.18 in the "little crash" of March/2020. We then proceed to expose what happened to this company, its future prospectus and its probable values by Peter Lynch's formula.
Oncology Highlights: Second Quarter Giving another emphasis on the previous post, I should mention as a general knowledge about the highlights of the Company cited. It is also worth mentioning that due to the costs of the platform domain, it is necessary to limit the content only to members who subscribe to this platform. The … Continue reading Unknown That Can Enrich You VERY MUCH in the Medium-Long Term.